Otto Soepenberg
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cancer therapeutics and mechanisms 8
- Oncology 7
- Lung Cancer Research Studies 4
- Neutropenia and Cancer Infections 2
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Jaap Verweij (11 shared papers)Alex Sparreboom (10 shared papers)Walter J. Loos (3 shared papers)Diederik F.S. Kehrer (1 shared paper)Maja J.A. de Jonge (5 shared papers)Ferry A.L.M. Eskens (3 shared papers)Ger‐Jan Sanderink (2 shared papers)Herlinde Dumez (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Annals of Oncology (2 papers)Clinical Cancer Research (2 papers)European Journal of Cancer (2 papers)Anti-Cancer Drugs (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Otto Soepenberg
14 papers receiving 353 citations
Peers
Comparison fields: 5 of 54
- Biomaterials 121
- Toxicology 25
- Oncology 131
- Pharmaceutical Science 28
- Molecular Medicine 20
Countries citing papers authored by Otto Soepenberg
This map shows the geographic impact of Otto Soepenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Soepenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Soepenberg more than expected).
Fields of papers citing papers by Otto Soepenberg
This network shows the impact of papers produced by Otto Soepenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Soepenberg. The network helps show where Otto Soepenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Otto Soepenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 102 | |
| 2 | 2005 | 78 | |
| 3 | 2005 | 69 | |
| 4 | 2004 | 32 | |
| 5 | 2005 | 25 | |
| 6 | 2007 | 21 | |
| 7 | 2003 | 12 | |
| 8 | 1994 | 9 | |
| 9 | 2004 | 9 | |
| 10 | 2017 | 7 | |
| 11 | 2003 | 7 | |
| 12 | 2011 | 2 | |
| 13 | 2003 | 1 | |
| 14 | 2004 | 1 |
About Otto Soepenberg
Otto Soepenberg is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Pharmacology and Neurology, having authored 14 papers that have together received 375 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (2 papers), Neutropenia and Cancer Infections (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Acute Myeloid Leukemia Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Biomaterials (121 citations), Toxicology (25 citations), Oncology (131 citations), Pharmaceutical Science (28 citations) and Molecular Medicine (20 citations). Otto Soepenberg has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Jaap Verweij, Alex Sparreboom, Walter J. Loos, Diederik F.S. Kehrer, Maja J.A. de Jonge, Ferry A.L.M. Eskens, Ger‐Jan Sanderink, Herlinde Dumez, Peter de Bruin and J. Wanders. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, European Journal of Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.